Welsis Corp. (WLSS) — SEC Financial Statements & Analysis

Welsis Corp. (WLSS) is a services-health services company, incorporated in WY. Welsis Corp. trades on OTC as: WLSS. Welsis Corp. (WLSS)'s most recent SEC filing is a Form 10-Q for the period ended 2025-12-31, filed with the SEC on 2026-02-17. Based on that filing, Welsis Corp. carries a market cap of $6.61M, a P/E ratio of -142.21x, a P/B ratio of -41.20x, a P/S ratio of 4817.17x, an enterprise value of $6.72M, and an EV/EBITDA multiple of -191.47x. On profitability, it posts an operating margin of -2894.90%, a net margin of -1234.15%, a Return on Equity (ROE) of 33.88%, and a Return on Assets (ROA) of -1775.76%. Per share, it reports EPS of $-0.02, diluted EPS of $-0.02, free cash flow per share of $-0.02, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 30.21% year-over-year, and EPS growth of 30.21% year-over-year. On the balance sheet, it maintains a current ratio of 0.01x, a quick ratio of 0.00x, working capital of $-81.93K, a debt-to-equity ratio of -1.01x, a debt ratio of 143.41, an interest coverage ratio of -3.10x, free cash flow of $-51.18K (TTM), and net debt of $118.42K. Figures sourced from SEC EDGAR.

Market Cap

$6.61M

P/E TTM

-142.21x

EPS TTM

$-0.02

P/B TTM

-41.20x

ROE TTM

33.88%

ROA TTM

-1775.76%

Debt To Equity

-1.01x

Free Cash Flow TTM

$-51.18K

Net Revenue TTM Growth 1Y

-100.00%

Data as of 2025-12-31 · Source: SEC EDGAR